Wenjing Li

机构：The University of Texas at San Antonio Health Science Center, Shandong Institute of Business and Technology · ORCID：0000-0001-9151-9219

发表论文 69 篇 · 总被引 1114 次 · h-index 20

代表论文

• Ginseng-derived nanoparticles alleviate inflammatory bowel disease via the TLR4/MAPK and p62/Nrf2/Keap1 pathways (2024 · Journal of Nanobiotechnology · 被引 83)
• Lysine-specific histone demethylase 1A (KDM1A/LSD1) inhibition attenuates DNA double-strand break repair and augments the efficacy of temozolomide in glioblastoma (2023 · Neuro-Oncology · 被引 51)
• Crucial roles of the BRCA1-BARD1 E3 ubiquitin ligase activity in homology-directed DNA repair (2023 · Molecular Cell · 被引 48)
• Promotion of DNA end resection by BRCA1–BARD1 in homologous recombination (2024 · Nature · 被引 39)
• BRCA1/BARD1 intrinsically disordered regions facilitate chromatin recruitment and ubiquitylation (2023 · The EMBO Journal · 被引 26)
• A high-permeability method for extracting purple yam saponins based on ultrasonic-assisted natural deep eutectic solvent (2024 · Food Chemistry · 被引 22)